40 Results

People

  1. Riely
    Riely
  2. Drilon
    Drilon
  3. Kris
    Kris
  4. Adusumilli
    Adusumilli
  5. Arbour
    Arbour
  6. Bains
    Bains
  7. Chakravarty
    Chakravarty
  8. Imber
    Imber
  9. Isbell
    Isbell
  10. Jones
    Jones

Groups

  1. Department of Medicine (31)
  2. Solid Tumor Oncology Division (30)
  3. Thoracic Oncology (29)
  4. Department of Pathology and Laboratory Medicine (7)
  5. Radiology, Department of (5)
  6. Weinberg Fellows (5)
  7. Body Imaging Service (4)
  8. Early Drug Development Service (4)
  9. Graduate Medical Education (4)
  10. Sloan Kettering Institute Postdocs (4)
  1. "alectinib"
Formats
  1. Journal Article (25)
  2. Review (7)
  3. Meeting Abstract (3)
  4. Conference Paper (2)
  5. Editorial (1)
  6. Guidelines (1)
  7. Research Letter (1)
Groups
  1. Department of Medicine (31)
  2. Solid Tumor Oncology Division (30)
  3. Thoracic Oncology (29)
  4. Department of Pathology and Laboratory Medicine (7)
  5. Radiology, Department of (5)
  6. Weinberg Fellows (5)

More Groups

People
  1. Gregory Riely (12)
  2. Alexander Drilon (11)
  3. Mark Kris (3)
  4. Adam Schoenfeld (2)
  5. Alison Schram (2)
  6. Andrew Plodkowski (2)

More People

Years
  1. 2025 (3)
  2. 2024 (4)
  3. 2023 (7)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (3)

More Years

Publications
  1. Journal of Thoracic Oncology (8)
  2. Cancer Discovery (3)
  3. Nature Reviews Clinical Oncology (3)
  4. Blood (2)
  5. JTO Clinical and Research Reports (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (9)
  2. American Association for Cancer Research (4)
  3. Nature Publishing Group (4)
  4. Elsevier Science, Inc. (3)
  5. American Society of Clinical Oncology (2)
  6. American Society of Hematology (2)

More Publishers

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Small molecules, big impact: 20 years of targeted therapy in oncology
    Review

    Bedard, P. L.; Hyman, D. M.; Davids, M. S.; Siu, L. L.
    Lancet (2020)

    Fulltext@MSK | Save
  • Efficacy of platinum/pemetrexed combination chemotherapy in ALK-positive NSCLC refractory to second-generation ALK inhibitors
    Journal Article

    Lin, J. J.; Schoenfeld, A. J.; Zhu, V. W.; Yeap, B. Y.; Chin, E.; Rooney, M.; Plodkowski, A. J.; Digumarthy, S. R.; Dagogo-Jack, I.; Gainor, J. F.; more...
    Journal of Thoracic Oncology (2020)

    Fulltext@MSK | Save
  • Treatment with next-generation ALK inhibitors fuels plasma ALK mutation diversity
    Journal Article

    Dagogo-Jack, I.; Rooney, M.; Lin, J. J.; Nagy, R. J.; Yeap, B. Y.; Hubbeling, H.; Chin, E.; Ackil, J.; Farago, A. F.; Hata, A. N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • ALK resistance mutations and efficacy of lorlatinib in advanced anaplastic lymphoma kinase-positive non–small-cell lung cancer
    Journal Article

    Shaw, A. T.; Solomon, B. J.; Besse, B.; Bauer, T. M.; Lin, C. C.; Soo, R. A.; Riely, G. J.; Ou, S. H. I.; Clancy, J. S.; Li, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Brigatinib in patients with alectinib-refractory ALK-positive NSCLC
    Journal Article

    Lin, J. J.; Zhu, V. W.; Schoenfeld, A. J.; Yeap, B. Y.; Saxena, A.; Ferris, L. A.; Dagogo-Jack, I.; Farago, A. F.; Taber, A.; Traynor, A.; more...
    Journal of Thoracic Oncology (2018)

    Fulltext@MSK | Save
  • Patient-reported outcomes in a phase II, North American study of alectinib in patients with ALK-positive, crizotinib-resistant, non-small cell lung cancer
    Journal Article

    Ou, S. H. I.; Socinski, M. A.; Gadgeel, S.; Gandhi, L.; West, H.; Chiappori, A. A.; Cohen, V.; Riely, G. J.; Smoljanovic, V.; Bordogna, W.; more...
    ESMO Open (2018)

    Fulltext@MSK | Save
  • Metastatic complications of cancer involving the central and peripheral nervous systems
    Journal Article

    Mendez, J. S.; DeAngelis, L. M.
    Neurologic Clinics (2018)

    Fulltext@MSK | Save
  • Targeting RET-driven cancers: Lessons from evolving preclinical and clinical landscapes
    Journal Article

    Drilon, A.; Hu, Z. I.; Lai, G. G. Y.; Tan, D. S. W.
    Nature Reviews Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Updated efficacy and safety data from the phase 2 NP28761 study of alectinib in ALK-positive non-small-cell lung cancer
    Meeting Abstract

    Camidge, D. R.; Gadgeel, S.; Ou, S. H.; Gandhi, L.; Riely, G.; Cetnar, J.; West, H.; Socinski, M.; Chiappori, A.; Mekhail, T.; more...
    Journal of Thoracic Oncology (2017)

    Fulltext@MSK | Save
  • Expanding the portfolio of anaplastic lymphoma kinase inhibitors for anaplastic lymphoma kinase-rearranged lung cancers
    Journal Article

    Santini, F. C.; Salhab, R. M.; Sharma, S.; Drilon, A.
    Translational Cancer Research (2017)

    Fulltext@MSK | Save